|

Comparison Chart of Illicit Heroin Addiction and Stabilized Methadone Maintenance

This chart was prepared by Herman Joseph and Joycelyn Sue
Woods and is reprinted from METHADONE TREATMENT WORKS: A COMPENDIUM FOR
METHADONE MAINTENANCE TREATMENT

Topic Illicit Heroin Addiction Stabilized Methadone Maintenance
Onset of action Immediate 30 minutes
Duration of action 4 – 6 hours 24 – 36 hours or half-life
Route of administration Injection, snorting, smoking ( several times a day ) Orally administered once per day
Effective dose Not applicable For many patients 60 mg/day is lowest effective dose; doses between
80 and 120 mgs/day are most effective for preventing HIV transmission
retention in treatment, reducing the use of other drugs and increasing
social productivity.
Overall safety potentially lethal Medically safe, no toxic effects found in patients maintained on
methadone for up to 18 years.
Overdose Can die from overdose of narcotics; potentially lethal, even for
tolerant individuals death can occur quite fast without proper medical
treatment with narcan.
A degree of protection from death by overdose is achieved when
receiving 100 mg/day or more; methadone is potentially lethal for
non-tolerant individuals, death can occur but more slowly than heroin
overdose however, overdose reaction can be reversed and person’s life
saved if narcotic antagonist such as narcan is prescribed for 24 – 36
hours
Narcotic effects of other opiates ( if tried ) Feels narcotic effects of opiates At 80 mgs/day or more narcotic effects of opiates are blocked
Withdrawal syndrome Can be severe, but can be controlled with methadone Less severe than heroin but more extended, can be controlled by
slow reduction in methadone dose
Mood alteration Constant swings None, if patient is not emotionally disturbed or using other drugs
Euphoric effects Approximately 2 hours duration after administration None after administration
Tolerance level Increasing dosage needed Stable level at some dose
Narcotic craving Recurring Relieved and blocked
HIV transmission Effective transmission Transmission of HIV by injection reduced or eliminated for patients
who remain in treatment
Immune and endocrine functioning in HIV- persons Impaired Normalizes during treatment
Immune and endocrine functioning in HIV+ persons Rapid progression to AIDS Preliminary studies indicate that the progression to AIDS is slower
Hypothalamus Pituitary Adrenal Axis Suppressed Normalizes during treatment
Sexual functioning / libido Impaired Normalizes during treatment
Female menses Impaired Normalizes during treatment
Pregnancy Serious problems difficult to treat Problems can be brought under control with medical, social and
prenatal care
Emotional affect Impaired Normal, if patient is not emotionally disturbed or using other
drugs
Pain and emotion Blunted Feels normal pain and experiences normal range of emotion if not
abusing other drugs
Intellectual functioning Impaired Normal if person is not emotionally disturbed or using other drugs
Physical reaction time Impaired Normalizes during treatment
Personal relationships Disrupted Restored with counseling
Social functioning Impaired Normalizes with counseling
Vocational rehabilitation and education High proportion of failure High proportion of success in vocational rehabilitation, education
and employability
Employment Difficult if not impossible to hold a job Can function in every level ant type of profession e.g.: bus
driver, lawyer, doctor, teacher, pilot
Mental illness Difficult to treat Treatable if integrated resources exists, however many psychiatric
services discriminate against methadone patients and will not accept
them
Poly-drug abuse High level ( alcohol, crack, cocaine, nicotine, etc. ) High level but potentially treatable
Criminal drug abuse Constant high level Reduced level or eliminated
Effect on community Destructive, high crime and death rates, transmission of disease A good methadone program contributes to public safety, reduces
mortality and improves quality of life for all
Criteria for addiction Fits criteria for addiction as listed in the “Diagnostic and
Statistical Manual of Mental Disorders”
Does not fit criteria for addiction, methadone maintenance is a
thoroughly researched and effective medical treatment
Life-style Heroin addiction is about acquired infection and death Methadone maintenance treatment is about good health and life.
Methadone chemotherapy normalizes a deranged physiology so patients can
stabilize their lives
This chart was prepared by Herman Joseph and Joycelyn
Sue Woods and is reprinted from METHADONE TREATMENT WORKS: A COMPENDIUM
FOR METHADONE MAINTENANCE TREATMENT
(Part 1) 1994: p 19-20. From the
Chemical Dependency Research Working Group Monograph Series, No. 2. New
York. New York State Office of Alcoholism and Substance Abuse Services (OASAS)
and Mental and Health Research Association of New York City, Inc. (MHRA).

For more information about the activities of the Chemical
Dependency Research Working Group (CDRWG) contact the Chair, Dr. Herman
Joseph at NYS OASAS, 55 West 125 Street, New York, NY 10025,(212)
961-8491, FAX (212) 961-8318

Similar Posts

  • The National Methadone Conference

    Admin 03/14/2023

    Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session  NAMA offers special thanks to Mallinckrodt. We also wish to thank Haworth Press, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without whose support the first Certified Methadone Advocate (CMA) Training Course would not…

  • The Advocacy Training Session

    Admin 12/18/2021

      The first training for certification will include a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs.   Addiction and Methadone– Tom Payte, MD (Drug Dependence Associates) and Joycelyn Woods, MA. (NAMA) The biological constructs of addiction will be explained in…

  • News

    Admin 08/25/2022

    Congratulations to Sara Gefvert, the 2022 Lane/Holden Award Winner! November 2, 2022 The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient…

  • Index

    Admin 10/15/2021

    Education Series 1 Methadone Maintenance and Patient Self Advocacy by Arlene Ford March 1991 Download File  (pdf format) Education Series 2 Drug Policy in the Age of AIDS: The Philosophy of Harm Reduction by Rod Sorge April 1991 Download File (pdf format) Education Series 3 Myths About Methadone by Emmet Velten, Ph.D. March 1992 Download File (pdf…

  • Executive Report

    Admin 09/19/2022

    LetterTo The Editor Birminghan Post-Herald, October 28, 2004 435 Second Avenue New York, NY 10010 (212) 595-6262 October 28, 2004 Re: Residents oppose a private methadone clinic in Saginaw by DANIEL Jackson (10/27/04). To the editor: It is wonderful to see an objective article about methadone treatment. The tendency is for the media to sensationalize…

  • Get Ready for National Recovery Month in September

    Admin 04/09/2021

    Get Ready for National Recovery Month in September NAMA declares 2005 THE YEAR OF RECOVERY FOR METHADONE PATIENTS Methadone patients have never been allowed to think of themselves as in recovery. This year the National Alliance of Methadone is declaring Recovery Month “The Year of Recovery for Methadone Patients.” Read the President’s Proclamation Time to…